Cargando…

Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis

Assess the efficiency and cost-effectiveness of infliximab, cyclosporine and tacrolimus for the treatment of ulcerative colitis (UC). METHODS: A literature search identified studies that investigated infliximab, cyclosporine or tacrolimus compared with placebo in UC patients. Short-term, long-term r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xueqi, Li, Qiubo, Sun, Shijiang, Liang, Xi, Li, Huijing, Huang, Jing, Zhao, Tianhe, Hu, Jingnan, Liu, Jianxin, Hu, Zhenbiao, Duan, Yangyang, He, Jianming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794301/ https://www.ncbi.nlm.nih.gov/pubmed/36595876 http://dx.doi.org/10.1097/MD.0000000000031850

Ejemplares similares

Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis
por: Jia, Xuemei, et al.
Publicado: (2020)

Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report
por: Gîlcă, Georgiana-Emmanuela, et al.
Publicado: (2017)

Meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: Acupoint catgut embedding treating ulcerative colitis meta-analysis
por: Yu, Yunfeng, et al.
Publicado: (2022)

Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy
por: Mizoshita, Tsutomu, et al.
Publicado: (2017)

Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis
por: Liu, Yi-Juan, et al.
Publicado: (2018)

Optimizing individualized management of patients with ulcerative colitis: Identification of risk factors predicting ulcerative colitis-associated neoplasia
por: Jiang, Wenyu, et al.
Publicado: (2023)

Efficacy of ginseng oral administration and ginseng injections on cancer-related fatigue: A meta-analysis
por: Li, Huijing, et al.
Publicado: (2022)

SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report
por: Alhalabi, Marouf, et al.
Publicado: (2022)

Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis
por: Sun, Dali, et al.
Publicado: (2016)

Huang Lian for ulcerative colitis: A protocol of systematic review and meta-analysis of randomized clinical trials
por: Li, Tinglin, et al.
Publicado: (2020)

Beverage consumption and risk of ulcerative colitis: Systematic review and meta-analysis of epidemiological studies
por: Nie, Jia-Yan, et al.
Publicado: (2017)

Integrated Traditional Chinese and Western medicine for ulcerative colitis with diabetes: A protocol for systematic review and meta-analysis
por: Lan, Yu-Ze, et al.
Publicado: (2021)

The ulcerative colitis endoscopic index of severity score is superior to reflecting long-term prognosis in ulcerative colitis patients treated with vedolizumab
por: Yan, Jing, et al.
Publicado: (2023)

Application of the neutrophil to lymphocyte ratio in the diagnosis and activity determination of ulcerative colitis: A meta-analysis and systematic review
por: Ma, Lushun, et al.
Publicado: (2021)

Efficacy and safety of methylphenidate and ginseng in cancer-related fatigue: a network meta-analysis of randomized controlled trials
por: Li, Huijing, et al.
Publicado: (2023)

Endocytoscopic classification can be predictive for relapse in ulcerative colitis
por: Ueda, Naoki, et al.
Publicado: (2018)

Ulcerative colitis and thrombocytosis: Case report and literature review
por: Zhou, Yaqi, et al.
Publicado: (2023)

Systematic review and meta-analysis of third-line salvage therapy with infliximab or cyclosporine in severe ulcerative colitis
por: Feuerstein, Joseph D., et al.
Publicado: (2016)

Efficacy and safety of bifid triple viable plus aminosalicylic acid for the treatment of ulcerative colitis: A systematic review and meta-analysis
por: Chen, Mu-yuan, et al.
Publicado: (2019)

Lymphocyte infiltration and key differentially expressed genes in the ulcerative colitis
por: Zhang, Junhui, et al.
Publicado: (2020)

Pathological mechanism and targeted drugs of ulcerative colitis: A review
por: Guo, Meitong, et al.
Publicado: (2023)

Efficacy and safety evaluation of acupoint embedding for patients with ulcerative colitis: A protocol of systematic review and meta-analysis
por: Lu, Jinhua, et al.
Publicado: (2020)

Use of Serum Infliximab Level Prior to Cyclosporine Salvage Therapy in Severe Ulcerative Colitis
por: Chapman, Christopher G., et al.
Publicado: (2014)

Features of the gut microbiota in ulcerative colitis patients with depression: A pilot study
por: Chen, De-Liang, et al.
Publicado: (2021)

Traditional Chinese medicine for mild-to-moderate ulcerative colitis: Protocol for a network meta-analysis of randomized controlled trials
por: Shen, Zhaofeng, et al.
Publicado: (2019)

Efficacy and safety evaluation of hyperbaric oxygen therapy for patients with ulcerative colitis: A protocol of systematic review and meta-analysis
por: Wang, Wei, et al.
Publicado: (2021)

Gallstone prevalence and risk factors in patients with ulcerative colitis in Korean population
por: Jeong, Yo Han, et al.
Publicado: (2017)

Ulcerative colitis with acute pleurisy: A case report and review of the literature
por: Lu, Shuming, et al.
Publicado: (2017)

Infliximab versus cyclosporine for severe ulcerative colitis refractory to steroids: A protocol for systematic review and meta-analysis
por: Wu, Dongjie, et al.
Publicado: (2018)

Clinical efficacy and safety of modified Sijunzi decoction for the treatment of ulcerative colitis: A protocol for a systematic review and meta-analysis
por: Tian, Shu Wei, et al.
Publicado: (2021)

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
por: Fasanmade, Adedigbo A., et al.
Publicado: (2009)

Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis
por: Uygun, Ahmet, et al.
Publicado: (2017)

Ustekinumab is effective against ulcerative colitis with intestinal stenosis: A case report
por: Liu, Ailing, et al.
Publicado: (2022)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Comparative of the effectiveness and safety of biological agents, small molecule drugs, and microbiome therapies in ulcerative colitis: Systematic review and network meta-analysis
por: Gao, Jie, et al.
Publicado: (2023)

Ulcerative colitis followed by the development of typical intestinal Behçet disease: A case report
por: Zhu, Zhenhua, et al.
Publicado: (2018)

Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study
por: de Campos Silva, Elen Farinelli, et al.
Publicado: (2020)

Intestinal flora differences between patients with ulcerative colitis of different ethnic groups in China
por: Liu, Huan, et al.
Publicado: (2021)

Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis
por: Malvão, Ludimilla dos Reis, et al.
Publicado: (2021)

Evaluation of the relationship between the spleen volume and the disease activity in ulcerative colitis and Crohn disease
por: Kawashima, Kazumasa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qq33smoihakaq376otvfg4fjbq